APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Fecal Microbiota Bank

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Fecal Microbiota Bank Market Analysis and Forecast 2026-2032

Report ID 174139300215 January 2026191 pages

Choose your research edition.

Industry ResearchFecal Microbiota Bank Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Fecal Microbiota Bank Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Fecal Microbiota Bank Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fecal Microbiota Bank Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Fecal Microbiota Bank Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Fecal Microbiota Bank market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Fecal Microbiota Bank is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Fecal Microbiota Bank is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Fecal Microbiota Bank is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Fecal Microbiota Bank is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Fecal Microbiota Bank include OpenBiome, Ramon Y Cajal, Asia Microbiota Bank, Taymount Clinic, FMT Bank, Birmingham MTC, BiomeBank, GoldBiome and Johns Hopkins, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Fecal Microbiota Bank, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Fecal Microbiota Bank, also provides the revenue of main regions and countries. Of the upcoming market potential for Fecal Microbiota Bank, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Fecal Microbiota Bank revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Fecal Microbiota Bank market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Fecal Microbiota Bank revenue, projected growth trends, production technology, application and end-user industry.

Fecal Microbiota Bank Segment by Company

OpenBiome

Ramon Y Cajal

Asia Microbiota Bank

Taymount Clinic

FMT Bank

Birmingham MTC

BiomeBank

GoldBiome

Johns Hopkins

Fecal Microbiota Bank Segment by Type

Fecal Bacteria Supply

FMT Treatment

Microbiome Testing

Other

Fecal Microbiota Bank Segment by Application

Hospital

Enterprise

Other

Fecal Microbiota Bank Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fecal Microbiota Bank market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fecal Microbiota Bank and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fecal Microbiota Bank.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Fecal Microbiota Bank in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Fecal Microbiota Bank company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fecal Microbiota Bank revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Fecal Microbiota Bank Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Fecal Bacteria Supply Major Player Table 3. FMT Treatment Major Player Table 4. Microbiome Testing Major Player Table 5. Other Major Player Table 6. Global Fecal Microbiota Bank Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Player Table 8. Enterprise Major Player Table 9. Other Major Player Table 10. Fecal Microbiota Bank Industry Trends Table 11. Fecal Microbiota Bank Industry Drivers Table 12. Fecal Microbiota Bank Industry Opportunities and Challenges Table 13. Fecal Microbiota Bank Industry Restraints Table 14. Global Fecal Microbiota Bank Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Fecal Microbiota Bank Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Fecal Microbiota Bank Market Share by Region (2021-2026) Table 17. Global Fecal Microbiota Bank Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Fecal Microbiota Bank Market Share by Region (2027-2032) Table 19. Global Fecal Microbiota Bank Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Fecal Microbiota Bank Revenue Market Share by Players (2021-2026) Table 21. Global Fecal Microbiota Bank Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Fecal Microbiota Bank Key Players Headquarters & Area Served Table 23. Global Fecal Microbiota Bank Players, Product Type & Application Table 24. Global Fecal Microbiota Bank Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Fecal Microbiota Bank by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Fecal Microbiota Bank Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Fecal Microbiota Bank Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Fecal Microbiota Bank Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Fecal Microbiota Bank Revenue Market Share by Type (2021-2026) Table 31. Global Fecal Microbiota Bank Revenue Market Share by Type (2027-2032) Table 32. Global Fecal Microbiota Bank Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Fecal Microbiota Bank Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Fecal Microbiota Bank Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Fecal Microbiota Bank Revenue Market Share by Application (2021-2026) Table 36. Global Fecal Microbiota Bank Revenue Market Share by Application (2027-2032) Table 37. OpenBiome Company Information Table 38. OpenBiome Business Overview Table 39. OpenBiome Fecal Microbiota Bank Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. OpenBiome Fecal Microbiota Bank Product Portfolio Table 41. OpenBiome Recent Development Table 42. Ramon Y Cajal Company Information Table 43. Ramon Y Cajal Business Overview Table 44. Ramon Y Cajal Fecal Microbiota Bank Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Ramon Y Cajal Fecal Microbiota Bank Product Portfolio Table 46. Ramon Y Cajal Recent Development Table 47. Asia Microbiota Bank Company Information Table 48. Asia Microbiota Bank Business Overview Table 49. Asia Microbiota Bank Fecal Microbiota Bank Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Asia Microbiota Bank Fecal Microbiota Bank Product Portfolio Table 51. Asia Microbiota Bank Recent Development Table 52. Taymount Clinic Company Information Table 53. Taymount Clinic Business Overview Table 54. Taymount Clinic Fecal Microbiota Bank Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Taymount Clinic Fecal Microbiota Bank Product Portfolio Table 56. Taymount Clinic Recent Development Table 57. FMT Bank Company Information Table 58. FMT Bank Business Overview Table 59. FMT Bank Fecal Microbiota Bank Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. FMT Bank Fecal Microbiota Bank Product Portfolio Table 61. FMT Bank Recent Development Table 62. Birmingham MTC Company Information Table 63. Birmingham MTC Business Overview Table 64. Birmingham MTC Fecal Microbiota Bank Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Birmingham MTC Fecal Microbiota Bank Product Portfolio Table 66. Birmingham MTC Recent Development Table 67. BiomeBank Company Information Table 68. BiomeBank Business Overview Table 69. BiomeBank Fecal Microbiota Bank Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. BiomeBank Fecal Microbiota Bank Product Portfolio Table 71. BiomeBank Recent Development Table 72. GoldBiome Company Information Table 73. GoldBiome Business Overview Table 74. GoldBiome Fecal Microbiota Bank Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. GoldBiome Fecal Microbiota Bank Product Portfolio Table 76. GoldBiome Recent Development Table 77. Johns Hopkins Company Information Table 78. Johns Hopkins Business Overview Table 79. Johns Hopkins Fecal Microbiota Bank Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Johns Hopkins Fecal Microbiota Bank Product Portfolio Table 81. Johns Hopkins Recent Development Table 82. North America Fecal Microbiota Bank Revenue by Type (2021-2026) & (US$ Million) Table 83. North America Fecal Microbiota Bank Revenue by Type (2027-2032) & (US$ Million) Table 84. North America Fecal Microbiota Bank Revenue by Application (2021-2026) & (US$ Million) Table 85. North America Fecal Microbiota Bank Revenue by Application (2027-2032) & (US$ Million) Table 86. North America Fecal Microbiota Bank Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. North America Fecal Microbiota Bank Revenue by Country (2021-2026) & (US$ Million) Table 88. North America Fecal Microbiota Bank Revenue by Country (US$ Million) & (2027-2032) Table 89. Europe Fecal Microbiota Bank Revenue by Type (2021-2026) & (US$ Million) Table 90. Europe Fecal Microbiota Bank Revenue by Type (2027-2032) & (US$ Million) Table 91. Europe Fecal Microbiota Bank Revenue by Application (2021-2026) & (US$ Million) Table 92. Europe Fecal Microbiota Bank Revenue by Application (2027-2032) & (US$ Million) Table 93. Europe Fecal Microbiota Bank Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. Europe Fecal Microbiota Bank Revenue by Country (2021-2026) & (US$ Million) Table 95. Europe Fecal Microbiota Bank Revenue by Country (US$ Million) & (2027-2032) Table 96. China Fecal Microbiota Bank Revenue by Type (2021-2026) & (US$ Million) Table 97. China Fecal Microbiota Bank Revenue by Type (2027-2032) & (US$ Million) Table 98. China Fecal Microbiota Bank Revenue by Application (2021-2026) & (US$ Million) Table 99. China Fecal Microbiota Bank Revenue by Application (2027-2032) & (US$ Million) Table 100. Asia Fecal Microbiota Bank Revenue by Type (2021-2026) & (US$ Million) Table 101. Asia Fecal Microbiota Bank Revenue by Type (2027-2032) & (US$ Million) Table 102. Asia Fecal Microbiota Bank Revenue by Application (2021-2026) & (US$ Million) Table 103. Asia Fecal Microbiota Bank Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Fecal Microbiota Bank Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 105. Asia Fecal Microbiota Bank Revenue by Region (US$ Million) & (2021-2026) Table 106. Asia Fecal Microbiota Bank Revenue by Region (US$ Million) & (2027-2032) Table 107. SAMEA Fecal Microbiota Bank Revenue by Type (2021-2026) & (US$ Million) Table 108. SAMEA Fecal Microbiota Bank Revenue by Type (2027-2032) & (US$ Million) Table 109. SAMEA Fecal Microbiota Bank Revenue by Application (2021-2026) & (US$ Million) Table 110. SAMEA Fecal Microbiota Bank Revenue by Application (2027-2032) & (US$ Million) Table 111. SAMEA Fecal Microbiota Bank Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. SAMEA Fecal Microbiota Bank Revenue by Country (2021-2026) & (US$ Million) Table 113. SAMEA Fecal Microbiota Bank Revenue by Country (US$ Million) & (2027-2032) Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Fecal Microbiota Bank Image Figure 2. Global Fecal Microbiota Bank Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fecal Microbiota Bank Market Size Share 2021 VS 2025 VS 2032 Figure 4. Fecal Bacteria Supply Image Figure 5. FMT Treatment Image Figure 6. Microbiome Testing Image Figure 7. Other Image Figure 8. Global Fecal Microbiota Bank Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Fecal Microbiota Bank Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Enterprise Image Figure 12. Other Image Figure 13. Global Fecal Microbiota Bank Market Size (US$ Million) & (2021-2032) Figure 14. Global Fecal Microbiota Bank Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Fecal Microbiota Bank Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Fecal Microbiota Bank Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Fecal Microbiota Bank Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Fecal Microbiota Bank Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Fecal Microbiota Bank Revenue Market Share by Type (2021-2032) Figure 21. Global Fecal Microbiota Bank Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Fecal Microbiota Bank Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Fecal Microbiota Bank Revenue Market Share by Application (2021-2032) Figure 24. North America Fecal Microbiota Bank Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Fecal Microbiota Bank Revenue Share by Type (2021-2032) Figure 26. North America Fecal Microbiota Bank Revenue Share by Application (2021-2032) Figure 27. North America Fecal Microbiota Bank Revenue Share by Country (2021-2032) Figure 28. United States Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Fecal Microbiota Bank Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Fecal Microbiota Bank Revenue Share by Type (2021-2032) Figure 33. Europe Fecal Microbiota Bank Revenue Share by Application (2021-2032) Figure 34. Europe Fecal Microbiota Bank Revenue Share by Country (2021-2032) Figure 35. Germany Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Fecal Microbiota Bank Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Fecal Microbiota Bank Revenue Share by Type (2021-2032) Figure 45. China Fecal Microbiota Bank Revenue Share by Application (2021-2032) Figure 46. Asia Fecal Microbiota Bank Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Fecal Microbiota Bank Revenue Share by Type (2021-2032) Figure 48. Asia Fecal Microbiota Bank Revenue Share by Application (2021-2032) Figure 49. Asia Fecal Microbiota Bank Revenue Share by Region (2021-2032) Figure 50. Japan Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Fecal Microbiota Bank Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Fecal Microbiota Bank Revenue Share by Type (2021-2032) Figure 58. SAMEA Fecal Microbiota Bank Revenue Share by Application (2021-2032) Figure 59. SAMEA Fecal Microbiota Bank Revenue Share by Country (2021-2032) Figure 60. Brazil Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Fecal Microbiota Bank Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Fecal Bacteria Supply
  • FMT Treatment
  • Microbiome Testing
  • Other
Applications
  • Hospital
  • Enterprise
  • Other
Companies covered
  • OpenBiome
  • Ramon Y Cajal
  • Asia Microbiota Bank
  • Taymount Clinic
  • FMT Bank
  • Birmingham MTC
  • BiomeBank
  • GoldBiome
  • Johns Hopkins

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Fecal Microbiota Bank Market by Type
  3. 1.2.1 Global Fecal Microbiota Bank Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Fecal Bacteria Supply
  5. 1.2.3 FMT Treatment
  6. 1.2.4 Microbiome Testing
  7. 1.2.5 Other
  8. 1.3 Fecal Microbiota Bank Market by Application
  9. 1.3.1 Global Fecal Microbiota Bank Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Enterprise
  12. 1.3.4 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Fecal Microbiota Bank Market Dynamics
  1. 2.1 Fecal Microbiota Bank Industry Trends
  2. 2.2 Fecal Microbiota Bank Industry Drivers
  3. 2.3 Fecal Microbiota Bank Industry Opportunities and Challenges
  4. 2.4 Fecal Microbiota Bank Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Fecal Microbiota Bank Market Perspective (2021-2032)
  2. 3.2 Global Fecal Microbiota Bank Growth Trends by Region
  3. 3.2.1 Global Fecal Microbiota Bank Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Fecal Microbiota Bank Market Size by Region (2021-2026)
  5. 3.2.3 Global Fecal Microbiota Bank Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Fecal Microbiota Bank Revenue by Players
  2. 4.1.1 Global Fecal Microbiota Bank Revenue by Players (2021-2026)
  3. 4.1.2 Global Fecal Microbiota Bank Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Fecal Microbiota Bank Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Fecal Microbiota Bank Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Fecal Microbiota Bank Key Players Headquarters & Area Served
  7. 4.4 Global Fecal Microbiota Bank Players, Product Type & Application
  8. 4.5 Global Fecal Microbiota Bank Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Fecal Microbiota Bank Market CR5 and HHI
  11. 4.6.3 2025 Fecal Microbiota Bank Tier 1, Tier 2, and Tier 3
5 Fecal Microbiota Bank Market Size by Type
  1. 5.1 Global Fecal Microbiota Bank Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Fecal Microbiota Bank Revenue by Type (2021-2032)
  3. 5.3 Global Fecal Microbiota Bank Revenue Market Share by Type (2021-2032)
6 Fecal Microbiota Bank Market Size by Application
  1. 6.1 Global Fecal Microbiota Bank Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Fecal Microbiota Bank Revenue by Application (2021-2032)
  3. 6.3 Global Fecal Microbiota Bank Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 OpenBiome
  2. 7.1.1 OpenBiome Company Information
  3. 7.1.2 OpenBiome Business Overview
  4. 7.1.3 OpenBiome Fecal Microbiota Bank Revenue and Gross Margin (2021-2026)
  5. 7.1.4 OpenBiome Fecal Microbiota Bank Product Portfolio
  6. 7.1.5 OpenBiome Recent Developments
  7. 7.2 Ramon Y Cajal
  8. 7.2.1 Ramon Y Cajal Company Information
  9. 7.2.2 Ramon Y Cajal Business Overview
  10. 7.2.3 Ramon Y Cajal Fecal Microbiota Bank Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Ramon Y Cajal Fecal Microbiota Bank Product Portfolio
  12. 7.2.5 Ramon Y Cajal Recent Developments
  13. 7.3 Asia Microbiota Bank
  14. 7.3.1 Asia Microbiota Bank Company Information
  15. 7.3.2 Asia Microbiota Bank Business Overview
  16. 7.3.3 Asia Microbiota Bank Fecal Microbiota Bank Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Asia Microbiota Bank Fecal Microbiota Bank Product Portfolio
  18. 7.3.5 Asia Microbiota Bank Recent Developments
  19. 7.4 Taymount Clinic
  20. 7.4.1 Taymount Clinic Company Information
  21. 7.4.2 Taymount Clinic Business Overview
  22. 7.4.3 Taymount Clinic Fecal Microbiota Bank Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Taymount Clinic Fecal Microbiota Bank Product Portfolio
  24. 7.4.5 Taymount Clinic Recent Developments
  25. 7.5 FMT Bank
  26. 7.5.1 FMT Bank Company Information
  27. 7.5.2 FMT Bank Business Overview
  28. 7.5.3 FMT Bank Fecal Microbiota Bank Revenue and Gross Margin (2021-2026)
  29. 7.5.4 FMT Bank Fecal Microbiota Bank Product Portfolio
  30. 7.5.5 FMT Bank Recent Developments
  31. 7.6 Birmingham MTC
  32. 7.6.1 Birmingham MTC Company Information
  33. 7.6.2 Birmingham MTC Business Overview
  34. 7.6.3 Birmingham MTC Fecal Microbiota Bank Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Birmingham MTC Fecal Microbiota Bank Product Portfolio
  36. 7.6.5 Birmingham MTC Recent Developments
  37. 7.7 BiomeBank
  38. 7.7.1 BiomeBank Company Information
  39. 7.7.2 BiomeBank Business Overview
  40. 7.7.3 BiomeBank Fecal Microbiota Bank Revenue and Gross Margin (2021-2026)
  41. 7.7.4 BiomeBank Fecal Microbiota Bank Product Portfolio
  42. 7.7.5 BiomeBank Recent Developments
  43. 7.8 GoldBiome
  44. 7.8.1 GoldBiome Company Information
  45. 7.8.2 GoldBiome Business Overview
  46. 7.8.3 GoldBiome Fecal Microbiota Bank Revenue and Gross Margin (2021-2026)
  47. 7.8.4 GoldBiome Fecal Microbiota Bank Product Portfolio
  48. 7.8.5 GoldBiome Recent Developments
  49. 7.9 Johns Hopkins
  50. 7.9.1 Johns Hopkins Company Information
  51. 7.9.2 Johns Hopkins Business Overview
  52. 7.9.3 Johns Hopkins Fecal Microbiota Bank Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Johns Hopkins Fecal Microbiota Bank Product Portfolio
  54. 7.9.5 Johns Hopkins Recent Developments
8 North America
  1. 8.1 North America Fecal Microbiota Bank Revenue (2021-2032)
  2. 8.2 North America Fecal Microbiota Bank Revenue by Type (2021-2032)
  3. 8.2.1 North America Fecal Microbiota Bank Revenue by Type (2021-2026)
  4. 8.2.2 North America Fecal Microbiota Bank Revenue by Type (2027-2032)
  5. 8.3 North America Fecal Microbiota Bank Revenue Share by Type (2021-2032)
  6. 8.4 North America Fecal Microbiota Bank Revenue by Application (2021-2032)
  7. 8.4.1 North America Fecal Microbiota Bank Revenue by Application (2021-2026)
  8. 8.4.2 North America Fecal Microbiota Bank Revenue by Application (2027-2032)
  9. 8.5 North America Fecal Microbiota Bank Revenue Share by Application (2021-2032)
  10. 8.6 North America Fecal Microbiota Bank Revenue by Country
  11. 8.6.1 North America Fecal Microbiota Bank Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Fecal Microbiota Bank Revenue by Country (2021-2026)
  13. 8.6.3 North America Fecal Microbiota Bank Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Fecal Microbiota Bank Revenue (2021-2032)
  2. 9.2 Europe Fecal Microbiota Bank Revenue by Type (2021-2032)
  3. 9.2.1 Europe Fecal Microbiota Bank Revenue by Type (2021-2026)
  4. 9.2.2 Europe Fecal Microbiota Bank Revenue by Type (2027-2032)
  5. 9.3 Europe Fecal Microbiota Bank Revenue Share by Type (2021-2032)
  6. 9.4 Europe Fecal Microbiota Bank Revenue by Application (2021-2032)
  7. 9.4.1 Europe Fecal Microbiota Bank Revenue by Application (2021-2026)
  8. 9.4.2 Europe Fecal Microbiota Bank Revenue by Application (2027-2032)
  9. 9.5 Europe Fecal Microbiota Bank Revenue Share by Application (2021-2032)
  10. 9.6 Europe Fecal Microbiota Bank Revenue by Country
  11. 9.6.1 Europe Fecal Microbiota Bank Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Fecal Microbiota Bank Revenue by Country (2021-2026)
  13. 9.6.3 Europe Fecal Microbiota Bank Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Fecal Microbiota Bank Revenue (2021-2032)
  2. 10.2 China Fecal Microbiota Bank Revenue by Type (2021-2032)
  3. 10.2.1 China Fecal Microbiota Bank Revenue by Type (2021-2026)
  4. 10.2.2 China Fecal Microbiota Bank Revenue by Type (2027-2032)
  5. 10.3 China Fecal Microbiota Bank Revenue Share by Type (2021-2032)
  6. 10.4 China Fecal Microbiota Bank Revenue by Application (2021-2032)
  7. 10.4.1 China Fecal Microbiota Bank Revenue by Application (2021-2026)
  8. 10.4.2 China Fecal Microbiota Bank Revenue by Application (2027-2032)
  9. 10.5 China Fecal Microbiota Bank Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Fecal Microbiota Bank Revenue (2021-2032)
  2. 11.2 Asia Fecal Microbiota Bank Revenue by Type (2021-2032)
  3. 11.2.1 Asia Fecal Microbiota Bank Revenue by Type (2021-2026)
  4. 11.2.2 Asia Fecal Microbiota Bank Revenue by Type (2027-2032)
  5. 11.3 Asia Fecal Microbiota Bank Revenue Share by Type (2021-2032)
  6. 11.4 Asia Fecal Microbiota Bank Revenue by Application (2021-2032)
  7. 11.4.1 Asia Fecal Microbiota Bank Revenue by Application (2021-2026)
  8. 11.4.2 Asia Fecal Microbiota Bank Revenue by Application (2027-2032)
  9. 11.5 Asia Fecal Microbiota Bank Revenue Share by Application (2021-2032)
  10. 11.6 Asia Fecal Microbiota Bank Revenue by Country
  11. 11.6.1 Asia Fecal Microbiota Bank Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Fecal Microbiota Bank Revenue by Country (2021-2026)
  13. 11.6.3 Asia Fecal Microbiota Bank Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Fecal Microbiota Bank Revenue (2021-2032)
  2. 12.2 SAMEA Fecal Microbiota Bank Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Fecal Microbiota Bank Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Fecal Microbiota Bank Revenue by Type (2027-2032)
  5. 12.3 SAMEA Fecal Microbiota Bank Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Fecal Microbiota Bank Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Fecal Microbiota Bank Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Fecal Microbiota Bank Revenue by Application (2027-2032)
  9. 12.5 SAMEA Fecal Microbiota Bank Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Fecal Microbiota Bank Revenue by Country
  11. 12.6.1 SAMEA Fecal Microbiota Bank Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Fecal Microbiota Bank Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Fecal Microbiota Bank Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst